Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

被引：393

作者：

Barouch, Dan H. ^{[1
,2
]}

Liu, Jinyan ^{[1
]}

Li, Hualin ^{[1
]}

Maxfield, Lori F. ^{[1
]}

Abbink, Peter ^{[1
]}

Lynch, Diana M. ^{[1
]}

Iampietro, M. Justin ^{[1
]}

SanMiguel, Adam ^{[1
]}

Seaman, Michael S. ^{[1
]}

Ferrari, Guido ^{[3
]}

Forthal, Donald N. ^{[4
]}

Ourmanov, Ilnour ^{[5
]}

Hirsch, Vanessa M. ^{[5
]}

Carville, Angela ^{[6
]}

Mansfield, Keith G. ^{[6
]}

Stablein, Donald ^{[7
]}

Pau, Maria G. ^{[8
]}

Schuitemaker, Hanneke ^{[8
]}

Sadoff, Jerald C. ^{[8
]}

Billings, Erik A. ^{[9
]}

Rao, Mangala ^{[9
]}

Robb, Merlin L. ^{[9
]}

Kim, Jerome H. ^{[9
]}

Marovich, Mary A. ^{[9
]}

Goudsmit, Jaap ^{[8
]}

Michael, Nelson L. ^{[9
]}

机构：

[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA

[2] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA

[3] Duke Univ, Med Ctr, Durham, NC 27710 USA

[4] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA

[5] NIAID, Bethesda, MA 20892 USA

[6] New England Primate Res Ctr, Southborough, MA 01772 USA

[7] EMMES Corp, Rockville, MD 20850 USA

[8] Crucell Holland BV, NL-2301 CA Leiden, Netherlands

[9] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA

来源：

NATURE | 2012年 / 482卷 / 7383期

基金：

美国国家卫生研究院;

关键词：

CELLULAR IMMUNE-RESPONSES; LOW-DOSE CHALLENGE; INFECTION; ANTIBODIES; MACAQUES; VECTORS; MEMORY; BREADTH;

D O I：

10.1038/nature10766

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection against acquisition of infection has previously only been reported against neutralization-sensitive virus challenges(1-3). Here we demonstrate vaccine protection against acquisition of fully heterologous, neutralization-resistant simian immunodeficiency virus (SIV) challenges in rhesus monkeys. Adenovirus/poxvirus and adenovirus/adenovirus-vector-based vaccines expressing SIVSME543 Gag, Pol and Env antigens resulted in an 80% or greater reduction in the per-exposure probability of infection(4,5) against repetitive, intrarectal SIVMAC251 challenges in rhesus monkeys. Protection against acquisition of infection showed distinct immunological correlates compared with post-infection virological control and required the inclusion of Env in the vaccine regimen. These data demonstrate the proof-of-concept that optimized HIV-1 vaccine candidates can block acquisition of stringent, heterologous, neutralization-resistant virus challenges in rhesus monkeys.

引用

页码：89 / U115

页数：6

共 50 条

[21] Protective immunity in rhesus monkeys immunized with replication-defective SIV vaccine
Tung, FY
Tung, LM
MacClure, HM
MOLECULAR THERAPY, 2003, 7 (05) : S265 - S266
[22] PROTECTION OF MONKEYS BY A SPLIT VACCINE AGAINST SIV(MAC) DEPENDS UPON BIOLOGICAL PROPERTIES OF THE CHALLENGE VIRUS
STAHLHENNIG, C
VOSS, G
DITTMER, U
COULIBALY, C
PETRY, H
MAKOSCHEY, B
CRANAGE, MP
AUBERTIN, AM
LUKE, W
HUNSMANN, G
AIDS, 1993, 7 (06) : 787 - 795
[23] Vaccination of rhesus monkeys with attenuated SIV: Immunological correlates of protection and safety aspects
Dittmer, U
StahlHennig, C
Nisslein, T
Petry, H
Hunsmann, G
Bodemer, W
VACCINES 97 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1997, : 279 - 283
[24] PROTECTION AGAINST VAGINAL SIV TRANSMISSION WITH MICROENCAPSULATED VACCINE
MARX, PA
COMPANS, RW
GETTIE, A
STAAS, JK
GILLEY, RM
MULLIGAN, MJ
YAMSHCHIKOV, GV
CHEN, DX
ELDRIDGE, JH
SCIENCE, 1993, 260 (5112) : 1323 - 1327
[25] Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Boopathy, Archana V.
Sharma, Bhawna
Nekkalapudi, Anurag
Wimmer, Raphaela
Gamez-Guerrero, Maria
Suthram, Silpa
Truong, Hoa
Lee, Johnny
Li, Jiani
Martin, Ross
Blair, Wade
Geleziunas, Romas
Orlinger, Klaus
Ahmadi-Erber, Sarah
Lauterbach, Henning
Makadzange, Tariro
Falkard, Brie
Schmidt, Sarah
NPJ VACCINES, 2023, 8 (01)
[26] Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
Archana V. Boopathy
Bhawna Sharma
Anurag Nekkalapudi
Raphaela Wimmer
Maria Gamez-Guerrero
Silpa Suthram
Hoa Truong
Johnny Lee
Jiani Li
Ross Martin
Wade Blair
Romas Geleziunas
Klaus Orlinger
Sarah Ahmadi-Erber
Henning Lauterbach
Tariro Makadzange
Brie Falkard
Sarah Schmidt
npj Vaccines, 8
[27] Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate (vol 83, pg 2686, 2009)
Yeh, Wendy W.
Jaru-ampornpan, Pimkwan
Nevidomskyte, Daiva
Asmal, Mohammed
Rao, Srinivas S.
Buzby, Adam P.
Montefiori, David C.
Korber, Bette T.
Letvin, Norman L.
JOURNAL OF VIROLOGY, 2009, 83 (10) : 5293 - 5293
[28] Accelerated Heterologous Adenovirus Prime-Boost SIV Vaccine in Neonatal Rhesus Monkeys
Liu, Jinyan
Li, Hualin
Lampietro, M. Justin
Barouch, Dan H.
JOURNAL OF VIROLOGY, 2012, 86 (15) : 7829 - 7835
[29] Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Jinyan Liu
Kara L. O’Brien
Diana M. Lynch
Nathaniel L. Simmons
Annalena La Porte
Ambryice M. Riggs
Peter Abbink
Rory T. Coffey
Lauren E. Grandpre
Michael S. Seaman
Gary Landucci
Donald N. Forthal
David C. Montefiori
Angela Carville
Keith G. Mansfield
Menzo J. Havenga
Maria G. Pau
Jaap Goudsmit
Dan H. Barouch
Nature, 2009, 457 : 87 - 91
[30] Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Liu, Jinyan
O'Brien, Kara L.
Lynch, Diana M.
Simmons, Nathaniel L.
La Porte, Annalena
Riggs, Ambryice M.
Abbink, Peter
Coffey, Rory T.
Grandpre, Lauren E.
Seaman, Michael S.
Landucci, Gary
Forthal, Donald N.
Montefiori, David C.
Carville, Angela
Mansfield, Keith G.
Havenga, Menzo J.
Pau, Maria G.
Goudsmit, Jaap
Barouch, Dan H.
NATURE, 2009, 457 (7225) : 87 - 91

← 1 2 3 4 5 →